NCT00006276View on ClinicalTrials.gov

Micellar Paclitaxel to Treat Severe Psoriasis

PHASE2CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

October 31, 2002

Conditions

Psoriasis

Interventions

DRUG

Micellar Paclitaxel

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00006276 - Micellar Paclitaxel to Treat Severe Psoriasis | Biotech Hunter | Biotech Hunter